SEC
SlamSEC
Search
Browse
Earnings
ALTEROLA BIOTECH INC. — SlamSEC
ALTEROLA BIOTECH INC.
OTC:
ABTI
Medicinal Chemicals & Botanical Products
·
BIRKENHEAD MERSEYSIDE, X0
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Overview
All Filings
Sum Fin
Credit
Insiders
Governance
Summary Financials
Revenue
$0
FY 2019
Adj. EBITDA
-$2.0M
FY 2024
Net Income
-$2.1M
FY 2024
EPS (Diluted)
—
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$0
FY 2020
Total Debt
$19,950
FY 2019
Net Debt
$19,950
FY 2019
Enterprise Value
—
Debt / EBITDA
-0.0x
FY 2019
EV / EBITDA
—
Employees
—